Holen Sie sich die Stockscreener-App
10.63
1.76%
-0.19
Handel nachbörslich:
10.68
0.05
+0.47%
Schlusskurs vom Vortag:
$10.82
Offen:
$10.74
24-Stunden-Volumen:
115.98K
Relative Volume:
0.46
Marktkapitalisierung:
$402.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.78M
KGV:
-3.9664
EPS:
-2.68
Netto-Cashflow:
$-53.91M
1W Leistung:
+1.82%
1M Leistung:
-5.26%
6M Leistung:
-16.95%
1J Leistung:
-29.60%
1-Tages-Spanne:
$10.50
$10.82
1-Wochen-Bereich:
$10.26
$10.88
52-Wochen-Spanne:
$7.575
$19.77
Celcuity Inc Stock (CELC) Company Profile
Firmenname
Celcuity Inc
Sektor
Branche
Telefon
763-392-0767
Adresse
16305 36TH AVENUE N, MINNEAPOLIS, MN
Vergleichen Sie CELC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
10.63 | 395.32M | 0 | -63.78M | -53.91M | -2.68 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-22 | Eingeleitet | Stifel | Buy |
| 2023-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-09-07 | Eingeleitet | Jefferies | Buy |
| 2021-07-29 | Eingeleitet | Cowen | Outperform |
| 2021-07-27 | Eingeleitet | Needham | Buy |
| 2021-01-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-11 | Fortgesetzt | Craig Hallum | Buy |
| 2018-11-20 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Celcuity Inc Aktie (CELC) Neueste Nachrichten
Bank of America Corp DE Has $3.77 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential By Investing.com - Investing.com Canada
Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential - Investing.com Australia
Ameriprise Financial Inc. Has $5.85 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Bought by Northern Trust Corp - Defense World
Q1 Earnings Estimate for Celcuity Issued By HC Wainwright - Defense World
HC Wainwright Analysts Lift Earnings Estimates for Celcuity - Defense World
Brokerages Set Celcuity Inc. (NASDAQ:CELC) Target Price at $30.80 - Defense World
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress - ACCESS Newswire
How To Trade (CELC) - news.stocktradersdaily.com
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences - GlobeNewswire
Celcuity’s (CELC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
HC Wainwright & Co. Reiterates Buy Rating on Celcuity (CELC) with $27 Target | CELC Stock News - GuruFocus
The Manufacturers Life Insurance Company Invests $142,000 in Celcuity Inc. (NASDAQ:CELC) - Defense World
Price T Rowe Associates Inc. MD Takes $167,000 Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Celcuity (NASDAQ:CELC) - Defense World
Celcuity outlines $2B peak revenue potential for gedatolisib as Phase 3 breast cancer trials progress - MSN
Celcuity Approves Stock Plan Amendment at Annual Meeting - TipRanks
Celcuity Inc. (NASDAQ:CELC) Q1 2025 Earnings Call Transcript - Insider Monkey
Celcuity (CELC) Maintains Strong "Buy" Rating from Needham | CEL - GuruFocus
Celcuity Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Celcuity Inc. Reports Q1 2025 Financial Results - TipRanks
Celcuity Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:CELC) - Seeking Alpha
Earnings call transcript: Celcuity Q1 2025 reports wider loss, stable stock - Investing.com
Transcript : Celcuity Inc., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
Celcuity (CELC) to Release Quarterly Earnings on Wednesday - Defense World
(CELC) Long Term Investment Analysis - news.stocktradersdaily.com
Celcuity Inc. (NASDAQ:CELC) Shares Acquired by Wells Fargo & Company MN - Defense World
MetLife Investment Management LLC Buys 6,669 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. to Release First Quarter 2025 Financial Results on May 14, 2025 - Nasdaq
Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call - GlobeNewswire
Barclays PLC Acquires 3,594 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
JPMorgan Chase & Co. Has $192,000 Stake in Celcuity Inc. (NASDAQ:CELC) - Defense World
Q1 Earnings Estimate for Celcuity Issued By Leerink Partnrs - Defense World
When (CELC) Moves Investors should Listen - news.stocktradersdaily.com
Brokerages Set Celcuity Inc. (NASDAQ:CELC) Price Target at $30.17 - Defense World
Celcuity Inc. Announces $50 Million Private Placement - ACCESS Newswire
Celcuity Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updates - ACCESS Newswire
Geode Capital Management LLC Acquires 62,003 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Is Celcuity (NASDAQ:CELC) Using Debt Sensibly? - simplywall.st
Celcuity Inc. (NASDAQ:CELC) Stock Holdings Lifted by Vanguard Group Inc. - Defense World
Where are the Opportunities in (CELC) - news.stocktradersdaily.com
Celcuity Inc. (NASDAQ:CELC) Shares Purchased by Wellington Management Group LLP - Defense World
Corebridge Financial Inc. Has $213,000 Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Needham & Company LLC Reiterates “Buy” Rating for Celcuity (NASDAQ:CELC) - Defense World
Celcuity at Needham Conference: New Frontiers in Cancer Treatment By Investing.com - Investing.com Canada
Celcuity at Stifel Forum: Insights on Cancer Drug Trials By Investing.com - Investing.com Canada
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Finanzdaten der Celcuity Inc-Aktie (CELC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):